title: Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia.
authors.affiliation: Haematology, Department of Cellular Biotechnologies and Haematology, "Sapienza" University, Rome, Italy. giona@bce.uniroma1.it.
authors.forename: Fiorina
authors.initials: F
authors.lastname: Giona
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Saglio
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Moleti
authors.forename: Alfonso
authors.initials: A
authors.lastname: Piciocchi
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Rea
authors.forename: Mauro
authors.initials: M
authors.lastname: Nanni
authors.forename: Deborah
authors.initials: D
authors.lastname: Marzella
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Testi
authors.forename: Sabrina
authors.initials: S
authors.lastname: Mariani
authors.forename: Marica
authors.initials: M
authors.lastname: Laurino
authors.forename: Daniela
authors.initials: D
authors.lastname: Diverio
authors.forename: Enrico
authors.initials: E
authors.lastname: Gottardi
authors.forename: Robin
authors.initials: R
authors.lastname: Foà
mesh_terms: D000293:Adolescent; D001549:Benzamides / Q000008:administration & dosage*; D002648:Child; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D012074:Remission Induction
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate
keywords: BCR-ABL1; childhood; chronic myeloid leukaemia; imatinib; treatment-free remission